CorMedix (CRMD) | Stock Overview & Key Data
CorMedix Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $52.00 on March 30, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CorMedix
CRMD
|
586.55M Small-cap | 1.43% | 8.10% | 19.94% | -19.74% | -29.77% | -30.48% | 64.20% | 13.29% | -37.94% | 6.84% | -31.38% |
|
Vertex
VRTX
|
109.45B Large-cap | -1.39% | 2.77% | -7.56% | -3.42% | -2.30% | 1.24% | 34.08% | 113.19% | 376.31% | 717.28% | 1,190.86% |
|
Regeneron
REGN
|
80.98B Large-cap | 1.16% | -11.35% | -20.16% | -13.01% | -19.01% | 25.39% | -16.92% | 20.10% | 53.41% | 959.24% | 4,557.42% |
|
Zymeworks
ZYME
|
1.96B Small-cap | -1.49% | -6.27% | -0.52% | -5.35% | -5.71% | 119.86% | 189.85% | -20.78% | 93.31% | 93.31% | 93.31% |
|
Amylyx
AMLX
|
1.91B Small-cap | 0.63% | -13.06% | -4.92% | -1.24% | 25.31% | 178.64% | -43.01% | -20.59% | -20.59% | -20.59% | -20.59% |
|
Syndax
SNDX
|
1.89B Small-cap | -8.76% | -9.72% | -16.65% | -8.71% | -15.40% | 85.86% | -4.30% | 9.75% | 48.41% | 65.32% | 65.32% |
Ownership & Short Interest
Calculate Your CorMedix Investment Returns
Long-Term Investment Performance Analysis
CorMedix stock price in Jun 2016 was $11.10, A $1,000.00 lump sum investment in CorMedix made 10 years ago would be worth approximately $753.15 today, representing a negative return of -24.68%. This translates to an annualized return (CAGR) of -2.80%.
9 Years 11 Months Investment Scenario (Jun 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CRMD's 52-week high and low?
- In the last 52 weeks, CorMedix reached a high of $17.43 (on June 23, 2025) and a low of $6.13 (on March 6, 2026).
- What is the market cap and P/E ratio for CRMD?
- Curious about CorMedix's size and valuation? Its market capitalization stands at 586.55M. When it comes to valuation, the P/E ratio (trailing twelve months) is 3.64, and the forward P/E (looking ahead) is 10.31.
- Does CRMD pay dividends? If so, what's the yield?
- As for dividends, CorMedix isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are CorMedix's main competitors or similar companies to consider before investing?
When looking at CorMedix, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology 1.24% 34.08% Regeneron
REGN80.98B Healthcare Biotechnology 25.39% -16.92% Zymeworks
ZYME1.96B Healthcare Biotechnology 119.86% 189.85% Amylyx
AMLX1.91B Healthcare Biotechnology 178.64% -43.01% Syndax
SNDX1.89B Healthcare Biotechnology 85.86% -4.30% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for CorMedix Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of CorMedix's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 66.56%, the Debt to Equity ratio from the most recent quarter is 36.74, and its Gross Profit Margin stands at 83.43%.
- What is the recent revenue and earnings growth for CRMD?
- Looking at CorMedix's growth, its revenue over the trailing twelve months (TTM) was $312M. Compared to the same quarter last year (YoY), quarterly revenue grew by 312.10%, and quarterly earnings saw a YoY growth of 4.10%.
- How much of CRMD stock is held by insiders and institutions?
- Wondering who owns CorMedix stock? Company insiders (like executives and directors) hold about 7.98% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 55.13%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.